Trial Profile
A compassionate use programme to assess the safety and tolerability of the combination of cabazitaxel and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 14 Jan 2019
Price :
$35
*
At a glance
- Drugs Cabazitaxel (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Adverse reactions; Expanded access
- 02 Dec 2015 New trial record